Cipla | CIPLA - Net Income

Stock Price
1,277.60
Daily Change
-22.40 -1.72%
Monthly
-5.35%
Yearly
-15.32%
Q1 Forecast
1,289.06

Cipla reported INR6.76B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Arca Biopharma USD -21M 4.78M Mar/2025
aTyr Pharma USD -25.74M 6.21M Sep/2025
Bio Path USD -2.85M 99K Mar/2025
Brainstorm Cell Therapeutics USD -2.86M 109K Mar/2025
Capricor Therapeutics USD -24.39M 17.27M Mar/2025
Cara Therapeutics USD -4.91M 2.77M Mar/2025
Cipla INR 6.76B 6.75B Dec/2025
Dr.Reddys Laboratories INR 12.1B 2.27B Dec/2025
Esperion Therapeutics USD 61.83M 93.16M Dec/2025
Immunic USD -24.37M 2.99M Sep/2024
Infinity Pharmaceuticals USD -9.96M 1.09M Jun/2023
Minerva Neurosciences USD 1.44M 21.07M Dec/2024
Nektar Therapeutics USD -37.06M 15.31M Sep/2024
Sangamo BioSciences USD -36.13M 12.96M Jun/2024
Sun Pharmaceuticals INR 33.69B 2.51B Dec/2025
TherapeuticsMD USD -1.09M 356K Jun/2024
UPL INR 3.96B 1.57B Dec/2025